{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:36:30Z","timestamp":1763958990063},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,29]]},"DOI":"10.7759\/cureus.15321","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T22:17:39Z","timestamp":1622326659000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer"],"prefix":"10.7759","author":[{"given":"Sachin","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshil","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorab","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"BCG vaccine. (2021). Accessed. May 29, 2021: https:\/\/www.who.int\/teams\/health-product-and-policy-standards\/standards-and-specifications\/vaccines-quality\/bcg."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(75)90503-8","article-title":"Study of local and systemic effects of intravesical BCG","volume":"5","author":"Schellhammer PF","year":"1975","unstructured":"Schellhammer PF, Kaplan MH, Pinsky CM, Whitmore WF Jr. Study of local and systemic effects of intravesical BCG. Urology. 1975, 5:562-7. 10.1016\/0090-4295(75)90503-8","journal-title":"Urology"},{"key":"ref3","article-title":"The bacillus Calmette-Guerin as immunomodulator in bladder cancer","volume":"59","author":"Vazquez-Lavista LG","year":"2007","unstructured":"Vazquez-Lavista LG, Flores-Balcazar CH, Llorente L. The bacillus Calmette-Guerin as immunomodulator in bladder cancer. Rev Invest Clin. 2007, 59:146-52.","journal-title":"Rev Invest Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn MA","year":"2014","unstructured":"P\u00e9rez-Jacoiste As\u00edn MA, Fern\u00e1ndez-Ruiz M, L\u00f3pez-Medrano F, et al.. Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore). 2014, 93:236-54. 10.1097\/MD.0000000000000119","journal-title":"Medicine (Baltimore)"},{"key":"ref5","unstructured":"Surveillance, epidemiology and end results program - cancer stat facts. bladder cancer. (2020). Accessed: May 29, 2021: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"key":"ref6","unstructured":"Bladder cancer treatment (PDQ\u00ae) - health professional version. (2021). Accessed. May 29, 2021: https:\/\/www.cancer.gov\/types\/bladder\/hp\/bladder-treatment-pdq.."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)58737-6","article-title":"Bruce, Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales A","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Bruce, Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976, 116:180-3. 10.1016\/s0022-5347(17)58737-6","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-018-0036-y","article-title":"Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma","volume":"1","author":"Wadhwani A","year":"2018","unstructured":"Wadhwani A, Moore RD, Bakshi D, Mirakhur A. Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma. CVIR Endovasc. 2018, 1:28. 10.1186\/s42155-018-0036-y","journal-title":"CVIR Endovasc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4136-9","article-title":"The first case of bacillus Calmette-Gu\u00e9rin-induced small-vessel central nervous system vasculitis","volume":"37","author":"Parent ME","year":"2018","unstructured":"Parent ME, Richer M, Liang P. The first case of bacillus Calmette-Gu\u00e9rin-induced small-vessel central nervous system vasculitis. Clin Rheumatol. 2018, 37:2297-302. 10.1007\/s10067-018-4136-9","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2007.26.5.671","article-title":"Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings","volume":"26","author":"Salvador R","year":"2007","unstructured":"Salvador R, Vilana R, Bargall\u00f3 X, Araque X, Nicolau C. Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings. J Ultrasound Med. 2007, 26:671-4. 10.7863\/jum.2007.26.5.671","journal-title":"J Ultrasound Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12931","article-title":"Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer","volume":"20","author":"Ziegler J","year":"2018","unstructured":"Ziegler J, Ho J, Gibson IW, Nayak JG, Stein M, Walkty A, Orr P. Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer. Transpl Infect Dis. 2018, 20:e12931. 10.1111\/tid.12931","journal-title":"Transpl Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.4.616","article-title":"Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation","volume":"38","author":"Leebeek FW","year":"1996","unstructured":"Leebeek FW, Ouwendijk RJ, Kolk AH, Dees A, Meek JC, Nienhuis JE, Dingemans-Dumas AM. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation. Gut. 1996, 38:616-8. 10.1136\/gut.38.4.616","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37369-x","article-title":"Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity","volume":"147","author":"DeHaven JI","year":"1992","unstructured":"DeHaven JI, Traynellis C, Riggs DR, Ting E, Lamm DL. Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity. J Urol. 1992, 147:738-42. 10.1016\/s0022-5347(17)37369-x","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.07.021","article-title":"Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG","volume":"65","author":"Brausi M","year":"2014","unstructured":"Brausi M, Oddens J, Sylvester R, et al.. Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014, 65:69-76. 10.1016\/j.eururo.2013.07.021","journal-title":"Eur Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200108000-00016","article-title":"Intravesical instillation of epirubicin, Bacillus Calmette-Guerin and Bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer Genito-urinary group randomized phase III trial","volume":"166","author":"van der Meijden AP","year":"2001","unstructured":"van der Meijden AP, Brausi M, Zambon V, Kirkels W, de Balincourt C, Sylvester R. Intravesical instillation of epirubicin, Bacillus Calmette-Guerin and Bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer Genito-urinary group randomized phase III trial. J Urol. 2001, 166:476-81. 10.1097\/00005392-200108000-00016","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.04.104","article-title":"The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study","volume":"176","author":"Colombel M","year":"2006","unstructured":"Colombel M, Saint F, Chopin D, Malavaud B, Nicolas L, Rischmann P. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study. J Urol. 2006, 176:935-9. 10.1016\/j.juro.2006.04.104","journal-title":"J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60467-a-case-of-systemic-toxicity-related-to-intravesical-bacillus-calmette-guerin-for-the-treatment-of-bladder-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:20Z","timestamp":1707506960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60467-a-case-of-systemic-toxicity-related-to-intravesical-bacillus-calmette-guerin-for-the-treatment-of-bladder-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.15321","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,29]]}}}